Arm Holdings plc - American Depositary Shares (ARM)
249.34
+0.00 (0.00%)
NASDAQ· Last Trade: Aug 20th, 9:21 AM EDT
Electric buses don't have time to sit around waiting for a slow charge — and that's exactly the problem pantograph chargers were built to solve. By droppin
Via Talk Markets · August 20, 2026
Exercise is one of the best ways to improve strength, flexibility, endurance, and overall health. Whether you enjoy running, weight training, cycling, swim
Via Talk Markets · August 20, 2026
Quick Q&AQ: What makes a rear windshield wiper reliable for KIA vehicles?A: A reliable rear wiper for KIA models comes down to accurate model-specific fitm
Via Talk Markets · August 20, 2026
Cema-cel hit 58.3% MRD negativity in ALPHA3 with zero treatment hospitalizations.
Via The Motley Fool · August 19, 2026
ARM Holdings (NASDAQ:ARM) Shows Strong Growth and a Technical Breakout Setupchartmill.com
Via Chartmill · August 14, 2026
When a company like SpaceX goes public, most people think about the headline event: a huge valuation, a stock ticker etc., what doesn't get talked about as
Via Talk Markets · August 19, 2026
The automotive aftermarket is often viewed through the most visible categories: engine components, brake systems, batteries, tires, and routine maintenance
Via Talk Markets · August 19, 2026
Stoke Therapeutics (NASDAQ:STOK) said its Phase III EMPEROR study of zorevunersen for Dravet syndrome has enrolled 162 patients, exceeding its target enrollment of 150, with no patient discontinuations reported to date.
Speaking at a Canaccord Genuity event, Chief Executive Officer Ian Smith said t
Via MarketBeat · August 17, 2026
Eyepoint Pharmaceuticals (NASDAQ:EYPT) reported topline results from LUGANO, the first of two Phase III trials evaluating DURAVYU, a vorolanib intravitreal insert, in patients with wet age-related macular degeneration, or wet AMD. The study did not meet its primary non-inferiority endpoint in the fu
Via MarketBeat · August 17, 2026
argenx (NASDAQ:ARGX) reported positive top-line results from its Phase III ALKIVIA trial of VYVGART Hytrulo in autoimmune myositis, meeting its primary endpoint in a combined population of patients with immune-mediated necrotizing myopathy, or IMNM, and dermatomyositis, or DM.
The study evaluated e
Via MarketBeat · August 17, 2026
The Department of Defense has been pushing contractors to ramp up production of critical munitions. RTX stock rose about 1% on Monday.
Via Investor's Business Daily · August 17, 2026
Neck pain accompanied by arm discomfort, numbness, tingling, or weakness can sometimes be associated with irritation or compression of a cervical spinal ne
Via Talk Markets · August 17, 2026
The quantum computing specialist now owns a chip factory that generates nearly twice its own revenue.
Via The Motley Fool · August 16, 2026
A sudden bout of dizziness. A brief moment where an arm feels weak, then feels fine again a few minutes later. Easy to dismiss, easy to explain away and so
Via Talk Markets · August 14, 2026
Let's have a look at one dirt-cheap Canadian dividend stock that seemingly got left behind as some of the nation's best income stars rose smoothly in this great TSX bull run.
Via The Motley Fool · August 13, 2026
CEO outlines manufacturing scale-up strategy for cell therapies amid $50.8M cash runway.
Via The Motley Fool · August 13, 2026
Asian market halts and currency-driven sell-offs can drag down NVIDIA, Micron, Advantest, Arm, and IBM despite steady AI and semiconductor demand, creating potential valuation opportunities.
Via MarketBeat · August 13, 2026
Arm stock could be the biggest beneficiary of a shift to CPU sales for AI.
Via The Motley Fool · August 13, 2026
Lonvo-z Phase III trial met primary endpoint with 87% attack reduction versus placebo.
Via The Motley Fool · August 13, 2026
The most encouraging aspect of the conglomerate's second-quarter report appears to have gone mostly overlooked.
Via The Motley Fool · August 13, 2026
Alphabet has turned into the Warren Buffett of Wall Street.
Via The Motley Fool · August 13, 2026
What You Should Know Before Replacing Toyota Corolla Suspension PartsFrom control arms and bushings to shock absorbers and stabilizer links, understanding
Via Talk Markets · August 13, 2026
SmartCentres REIT (TSX:SRU.UN) and another dividend play both have a nice value focus.
Via The Motley Fool · August 12, 2026
A new business strategy could have huge implications for ARM Holdings.
Via The Motley Fool · August 11, 2026
Phase 2 ovarian cancer data shows 45.1-month survival versus 30.4 months in control arm.
Via The Motley Fool · August 11, 2026